Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYRO3 | Q06418 | 6/20 | 0.64 |
| ▸ | JAK3 | P52333 | 6/20 | 0.64 |
| ▸ | BTK | Q06187 | 6/20 | 0.64 |
| ▸ | JAK2 | O60674 | 4/20 | 0.64 |
| ▸ | AURKA | O14965 | 2/20 | 0.64 |
| ▸ | DAPK3 | O43293 | 2/20 | 0.64 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.64 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.64 |
| ▸ | PAK4 | O96013 | 2/20 | 0.64 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.64 |
| ▸ | CSF1R | P07333 | 2/20 | 0.64 |
| ▸ | RET | P07949 | 2/20 | 0.64 |
| ▸ | IGF1R | P08069 | 2/20 | 0.64 |
| ▸ | MET | P08581 | 2/20 | 0.64 |
| ▸ | PIM1 | P11309 | 2/20 | 0.64 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.64 |
| ▸ | PRKACA | P17612 | 2/20 | 0.64 |
| ▸ | FLT1 | P17948 | 2/20 | 0.64 |
| ▸ | LTK | P29376 | 2/20 | 0.64 |
| ▸ | GRK5 | P34947 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16793724 | 0.84 | JAK3 (0.67) | TYRO3JAK3BTKJAK2AURKA | |
| SCHEMBL18195427 | 0.84 | JAK2 (0.55) | TYRO3JAK3BTKJAK2AURKA | |
| SCHEMBL29986767 | 0.84 | JAK3 (0.67) | TYRO3JAK3BTKJAK2AURKA | |
| SCHEMBL18197623 | 0.83 | BTK (0.61) | TYRO3JAK3BTKJAK2AURKA | |
| SCHEMBL16793578 | 0.83 | BTK (0.61) | TYRO3JAK3BTKJAK2AURKA | |
| SCHEMBL24804206 | 0.82 | ENPP1 (0.56) | TYRO3JAK3BTKJAK2AURKA | |
| SCHEMBL15662726 | 0.81 | JAK2 (0.80) | TYRO3JAK3BTKJAK2AURKA | |
| SCHEMBL16793693 | 0.81 | TBK1 (0.55) | TYRO3JAK3BTKJAK2AURKA | |
| SCHEMBL26953407 | 0.80 | CCNK (0.53) | TYRO3JAK3JAK2DAPK3PRKD3 | |
| SCHEMBL16793627 | 0.77 | JAK2 (0.66) | TYRO3JAK3BTKJAK2AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220411420-A1 | PYRROLOPYRIMIDINE DERIVATIVE HAVING ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE INHIBITORY ACTIVITY AND USE THEREOF | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2022-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411420-A1 | PYRROLOPYRIMIDINE DERIVATIVE HAVING ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE INHIBITORY ACTIVITY AND USE THEREOF | ENPP1, ENPP3, PPA1 | TYRO3 3922/4885JAK3 4097/4885BTK 3831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.